NCT02202967View on ClinicalTrials.gov

Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs

PHASE3CompletedINTERVENTIONAL

Enrollment

104

Participants

Timeline

Start Date

January 7, 2016

Primary Completion Date

October 11, 2017

Study Completion Date

October 11, 2017

Conditions

Chronic ArthritisIschemic Heart DiseaseAtrial FibrillationAnemiaBleeding

Interventions

DRUG

Misoprostol

Misoprostol oral tablets/ capsules contain 200 mcg of Misoprostol, a synthetic prostaglandin E1 analog

DRUG

Placebo

Placebo contains lactose granules

Trial Locations (1)

KA2 0BE

University Hospital Crosshouse, Kilmarnock

All Listed Sponsors

lead

NHS Greater Glasgow and Clyde

OTHER

NCT02202967 - Misoprostol for Small Bowel Ulcers and Obscure Bleeding Due to Aspirin or Nonsteroidal Antiinflammatory Drugs | Biotech Hunter | Biotech Hunter